Andrés Esteban-Cantos

637 total citations
14 papers, 253 citations indexed

About

Andrés Esteban-Cantos is a scholar working on Virology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Andrés Esteban-Cantos has authored 14 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 7 papers in Emergency Medicine and 6 papers in Infectious Diseases. Recurrent topics in Andrés Esteban-Cantos's work include HIV Research and Treatment (9 papers), HIV-related health complications and treatments (7 papers) and Cytomegalovirus and herpesvirus research (5 papers). Andrés Esteban-Cantos is often cited by papers focused on HIV Research and Treatment (9 papers), HIV-related health complications and treatments (7 papers) and Cytomegalovirus and herpesvirus research (5 papers). Andrés Esteban-Cantos collaborates with scholars based in Spain, France and Germany. Andrés Esteban-Cantos's co-authors include Javier Rodríguez-Centeno, José Ramón Arribas, Berta Rodés, Julen Cadiñanos, Rocío Montejano, Rosa de Miguel Buckley, José Ignacio Bernardino, Natalia Stella-Ascariz, Belén Alejos and Eulalia Valencia and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Andrés Esteban-Cantos

13 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrés Esteban-Cantos Spain 10 100 92 88 88 53 14 253
Chiara Montrucchio Italy 9 63 0.6× 41 0.4× 126 1.4× 83 0.9× 23 0.4× 14 211
A. I. M. Hoepelman Netherlands 12 64 0.6× 49 0.5× 108 1.2× 172 2.0× 18 0.3× 21 349
Margherita Digaetano Italy 9 99 1.0× 41 0.4× 131 1.5× 64 0.7× 31 0.6× 19 253
Guglielmo Marco Migliorino Italy 10 56 0.6× 34 0.4× 106 1.2× 50 0.6× 15 0.3× 20 201
Luz Alicia González-Hernández Mexico 10 98 1.0× 82 0.9× 158 1.8× 97 1.1× 150 2.8× 35 386
María Lagarde Spain 8 94 0.9× 42 0.5× 131 1.5× 52 0.6× 47 0.9× 23 200
Gabriella De Girolamo Italy 8 87 0.9× 92 1.0× 109 1.2× 50 0.6× 105 2.0× 12 290
Stefano Savinelli Ireland 8 44 0.4× 63 0.7× 72 0.8× 69 0.8× 32 0.6× 23 238
Juan Tiraboschi Spain 13 244 2.4× 108 1.2× 312 3.5× 81 0.9× 27 0.5× 51 382
Melania Degli Antoni Italy 10 89 0.9× 23 0.3× 139 1.6× 76 0.9× 85 1.6× 24 302

Countries citing papers authored by Andrés Esteban-Cantos

Since Specialization
Citations

This map shows the geographic impact of Andrés Esteban-Cantos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrés Esteban-Cantos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrés Esteban-Cantos more than expected).

Fields of papers citing papers by Andrés Esteban-Cantos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrés Esteban-Cantos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrés Esteban-Cantos. The network helps show where Andrés Esteban-Cantos may publish in the future.

Co-authorship network of co-authors of Andrés Esteban-Cantos

This figure shows the co-authorship network connecting the top 25 collaborators of Andrés Esteban-Cantos. A scholar is included among the top collaborators of Andrés Esteban-Cantos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrés Esteban-Cantos. Andrés Esteban-Cantos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Esteban-Cantos, Andrés, et al.. (2024). Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians. The Lancet HIV. 11(5). e333–e340. 8 indexed citations
2.
Cadiñanos, Julen, Javier Rodríguez-Centeno, Rocío Montejano, et al.. (2024). Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1. Open Forum Infectious Diseases. 11(10). ofae550–ofae550.
3.
Esteban-Cantos, Andrés, Christian Thorball, Berta Rodés, et al.. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet Healthy Longevity. 4(5). e211–e218. 21 indexed citations
4.
Bernardino, José Ignacio, Belén Alejos, Javier Rodríguez-Centeno, et al.. (2023). Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV. Microorganisms. 11(7). 1818–1818. 2 indexed citations
5.
Esteban-Cantos, Andrés, Javier Rodríguez-Centeno, Juan Carlos Silla-Castro, et al.. (2023). Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns. EBioMedicine. 88. 104434–104434. 14 indexed citations
6.
Buckley, Rosa de Miguel, Rocío Montejano, María Jiménez-González, et al.. (2022). Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance. Open Forum Infectious Diseases. 9(11). ofac610–ofac610. 7 indexed citations
7.
Rodés, Berta, Julen Cadiñanos, Andrés Esteban-Cantos, Javier Rodríguez-Centeno, & José Ramón Arribas. (2022). Ageing with HIV: Challenges and biomarkers. EBioMedicine. 77. 103896–103896. 58 indexed citations
8.
Esteban-Cantos, Andrés, Rocío Montejano, Javier Rodríguez-Centeno, et al.. (2021). Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus–Infected Recipients of Long-term Antiretroviral Treatment. The Journal of Infectious Diseases. 225(2). 287–294. 15 indexed citations
9.
Rodríguez-Centeno, Javier, Andrés Esteban-Cantos, Rocío Montejano, et al.. (2021). Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults. Journal of Antimicrobial Chemotherapy. 77(4). 1125–1132. 12 indexed citations
10.
Alejos, Belén, Natalia Stella-Ascariz, Rocío Montejano, et al.. (2019). Determinants of blood telomere length in antiretroviral treatment‐naïve HIV‐positive participants enrolled in the NEAT 001/ANRS 143 clinical trial. HIV Medicine. 20(10). 691–698. 13 indexed citations
11.
Montejano, Rocío, Natalia Stella-Ascariz, Susana Monge, et al.. (2018). Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV–Infected Adults. The Journal of Infectious Diseases. 218(10). 1531–1540. 27 indexed citations
12.
Stella-Ascariz, Natalia, Rocío Montejano, Javier Rodríguez-Centeno, et al.. (2018). Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1. The Journal of Infectious Diseases. 218(10). 1523–1530. 25 indexed citations
14.
Esteban-Cantos, Andrés, Belén Aracil, Verónica Bautista, et al.. (2017). The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population. Antimicrobial Agents and Chemotherapy. 61(4). 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026